INS1007

· Insmed Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INS1007, covering 2023-02-08 to 2023-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis [Phase 2]